Company News

Share this article:

Aventis Pharmaceutical, a subsidiary of Sanofi-Aventis, will pay $95.5 million to settle Department of Justice allegations that it violated the False Claims Act by misreporting drug prices to reduce its Medicaid Drug Rebate obligations. The allegations refer to pricing on Azmacort, Nasacort and Nasacort AQ, between 1995 and 2000.

 

WeissComm Group announced the acquisition of Common Sense Media Group, a social media consulting company founded by Bob Pearson, who will become WeissComm's chief technology and media officer. WeissComm also signed a strategic alliance with Rule 13, a firm focused on social media education, research and training.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.